منابع مشابه
Social Pharmacy and Clinical Pharmacy—Joining Forces
This commentary seeks to define the areas of social pharmacy and clinical pharmacy to uncover what they have in common and what still sets them apart. Common threats and challenges of the two areas are reviewed in order to understand the forces in play. Forces that still keep clinical and social pharmacy apart are university structures, research traditions, and the management of pharmacy servic...
متن کاملClinical pharmacy and clinical trials
CPC-148 Table 1 adalimumab infliximab ustekinumab Lost to follow-up 5% (1/20) 23.5% (4/17) 22% (2/9) Continuing treatment 40% (8/20) 29.4% (5/17) 67% (6/9) Withdrawal/ Discontinuation by doctor 5% (1/20) 5.9% (1/17) 11% (1/9) Discontinuation due to good response 20% (4/20) – – Change of treatment 30% (6/20) 41.2% (7/17) – The causes of the discontinuation/change of treatment were: Abstract CPC-...
متن کاملFront-line clinical pharmacy
Background There is strong evidence supporting that pharmacist involvement strengthens the quality of the medication process. There is also evidence indicating that many emergency admissions among the elderly are medicine related. Based on this existing knowledge, it was decided to investigate whether implementation of clinical pharmacy in the Emergency Department could make a further difference.
متن کاملClinical pharmacy services, pharmacy staffing, and hospital mortality rates.
OBJECTIVE To determine if hospital-based clinical pharmacy services and pharmacy staffing continue to be associated with mortality rates. METHODS A database was constructed from 1998 MedPAR, American Hospital Association's Annual Survey of Hospitals, and National Clinical Pharmacy Services databases, consisting of data from 2,836,991 patients in 885 hospitals. Data from hospitals that had 14 ...
متن کاملAmerican college of clinical pharmacy.
agents, Dr. Malesker noted variable responses with enalaprilat, a risk of extravasation with esmolol, hypotension with labetalol, rapidly developing resistance to nitroglycerin, and toxicity in patients with impaired hepatic or renal function with nitroprusside. He concluded, “In addition to the lower overall treatment cost, the higher acquisition cost of nicardipine is offset by a greater mono...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Drug Intelligence & Clinical Pharmacy
سال: 1988
ISSN: 0012-6578
DOI: 10.1177/106002808802201117